Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein, Chung‐Han Lee, Alexander Noor Shoushtari, Matthew David Hellmann, Ronglai Shen, Yelena Yuriy Janjigian, David A. Barron, Ahmet Zehir, Emmet Jordan, Antonio M. P. Omuro, Thomas Joseph Kaley, Sviatoslav M. Kendall, Robert John Motzer, A. Ari Hakimi, Martin Henner Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat A Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, and 32 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1038/s41588-018-0312-8
- Published
- Jan 8, 2019
- Venue
- Nature Genetics
- DOI
- 10.1038/s41588-018-0312-8
- PubMed
- 30643254
- Categories
- Cancer Immunotherapy and Biomarkers
- Provenance
- openalex